Arcadia Biosciences (RKDA) Return on Sales (2014 - 2025)

Arcadia Biosciences' Return on Sales history runs 12 years deep, the most recent figure standing at 0.0% for Q3 2025.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.0% (up 1.0% YoY) and the FY2024 annual result came in at 0.01%, up 1.0% from the prior year.
• Return on Sales was 0.0% for Q3 2025 at Arcadia Biosciences, up from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.17% in Q4 2021 and bottomed at 0.03% in Q3 2021.
• A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2021 — Return on Sales jumped 35 bps — and 2022, when it fell 16 bps.
• Arcadia Biosciences' Return on Sales stood at 0.17% in 2021, then sank by 99 bps to 0.0% in 2022, then slumped by 1515 bps to 0.03% in 2023, then jumped by 99 bps to 0.0% in 2024, then soared by 76 bps to 0.0% in 2025.
• Business Quant data shows RKDA's Return on Sales at 0.0% in Q3 2025, 0.0% in Q2 2025, and 0.0% in Q1 2025.